Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Abstracts

Abstracts

  • Monday, September 30, 2024
  • 8:00 AM – 8:10 AM ET
    165 - Long-Term Prognostic Analysis of Chemoradiotherapy vs. Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results from a Prospective Randomized Control Study
    Location: Room 151
    Presenter: Xiaxi Qiao, MD
  • 8:10 AM – 8:20 AM ET
    166 - Combination of Radiotherapy and Nivolumab for Previously Treated Advanced Gastric Cancer (CIRCUIT Trial): 3-Years Update
    Location: Room 151
    Presenter: Yoshiyuki Suzuki, MD, PhD – Fukushima Medical University
  • 8:20 AM – 8:30 AM ET
    167 - Personalized Minimal Residual Disease Profiling Predicts Prognosis in Esophageal Carcinoma Undergoing Definitive Radiotherapy
    Location: Room 151
    Presenter: Lin-rui Gao, MD – Chinese Academy of Medical Sciences and Peking Union Medical College
  • 8:30 AM – 8:40 AM ET
    168 - Neoadjuvant Toripalimab plus Concurrent Chemoradiotherapy in the Locally Advanced Adenocarcinoma of Esophagogastric Junction: A Phase II Trial
    Location: Room 151
    Presenter: Rongxu Du, MD – Beijing Cancer Hospital
  • 8:40 AM – 8:50 AM ET
    169 - Quality of Life Among Long-Term Survivors of Oesophageal Cancer Cured By Definitive Radiotherapy: A Cross-Sectional Study
    Location: Room 151
    Presenter: Qingsong Pang, MD, PhD – Tianjin Cancer Hospital
  • 8:50 AM – 9:00 AM ET
    Discussant
    Location: Room 151
    Discussant: Abraham Wu, MD – Memorial Sloan Kettering Cancer Center
  • 8:00 AM – 8:10 AM ET
    170 - Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results from a Prospective Clinical Trial
    Location: Room 204
    Presenter: Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center
  • 8:10 AM – 8:20 AM ET
    171 - Whole Lung Irradiation in Rhabdomyosarcoma with Lung Metastases: A Report from the Soft Tissue Sarcoma Committee of the Childrens Oncology Group
    Location: Room 204
    Presenter: Leo Luo, MD – Vanderbilt University Medical Center
  • 8:20 AM – 8:30 AM ET
    172 - Establishing the Association between OAR Dose and Post-Therapy Scholastic Performance in Pediatric Brain Tumor Survivors
    Location: Room 204
    Presenter: Raymond Mailhot Vega, MD, MPH – University of Florida Proton Therapy Institute
  • 8:30 AM – 8:40 AM ET
    173 - Interplay of Radiation and Cyclophosphamide Doses on Local Control in Children with Group III Rhabdomyosarcoma: An Analysis of Studies from the Childrens Oncology Group
    Location: Room 204
    Presenter: Margaret Kozak, MD – UT Southwestern Medical Center
  • 8:40 AM – 8:50 AM ET
    174 - Stereotactic Body Radiation Therapy (SBRT) for Metastatic Osteosarcoma: Local Control Outcomes with Local Failure Dosimetric Analysis
    Location: Room 204
    Presenter: Jenna Kocsis, MD – Cleveland Clinic Taussig Cancer Center
  • 8:50 AM – 9:00 AM ET
    Discussant
    Location: Room 204
    Discussant: Paul Aridgides, MD – SUNY Upstate Medical University
  • 8:00 AM – 8:10 AM ET
    160 - Convection-Enhanced Drug Delivery and Radiosensitization for Diffuse Midline Glioma
    Location: Room 144
    Presenter: Matthew Gallitto, MD, PhD – Columbia University Irving Medical Center
  • 8:10 AM – 8:20 AM ET
    161 - Exploring the Combined Effects of Tamoxifen and Radiotherapy, Regardless of Estrogen Receptor Status
    Location: Room 144
  • 8:20 AM – 8:30 AM ET
    162 - A Precision Oncology Platform to Target CDK4/6 Inhibitor Resistance
    Location: Room 144
    Presenter: Kamal Pandey, PhD – UT Southwestern Medical Center at Dallas
  • 8:30 AM – 8:40 AM ET
    163 - Novel Radiosensitizer Screen Identifies an Effective Strategy to Treat p53 Wild-Type Breast Cancer Models in a Hormone Independent Manner
    Location: Room 144
    Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
  • 8:40 AM – 8:50 AM ET
    164 - Synergistic Potential of CDK4/6 Inhibitors and Radiotherapy with Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer
    Location: Room 144
    Presenter: Wen-Chi Yang, MD – National Taiwan University Hospital
  • 8:50 AM – 9:00 AM ET
    Discussant
    Location: Room 144
    Discussant: Nadeem Riaz, MD, MS – Memorial Sloan Kettering Cancer Center
  • 8:00 AM – 8:10 AM ET
    175 - Unlocking the Simulation-Omitted Spine SAbR: Advancing Efficiency with Advanced CBCT and Online Adaptive Therapy
    Location: Room 152
    Presenter: Da Wang, PhD – UT Southwestern Medical Center
  • 8:10 AM – 8:20 AM ET
    176 - Enabling Conventional Single-Energy CT Systems to Incorporate Dual-Energy CT Functionalities by Multimodality Deep Learning
    Location: Room 152
    Presenter: Lei Xing, PhD, FASTRO – Stanford University
  • 8:20 AM – 8:30 AM ET
    177 - MRI for Spinal Cord Visualization near Surgical Hardware to Replace CT Myelogram for Spine Sarcoma Radiotherapy
    Location: Room 152
    Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute
  • 8:30 AM – 8:40 AM ET
    178 - CT-Ventilation Using Swin UNETR Networks for Automated Lobe Segmentation
    Location: Room 152
    Presenter: Gabriela Oliveira Nomura, BS – Dell Seton Medical Center at the University of Texas
  • 8:40 AM – 8:50 AM ET
    179 - Results of a Prospective Trial to Evaluate Novel Lung Function Imaging for Lung Cancer Surgery
    Location: Room 152
    Presenter: Lydia Wilson, PhD – Thomas Jefferson University
  • 8:50 AM – 9:00 AM ET
    180 - Assessing the Tumor Visibility and Respiratory Motion of Liver Cancer Patients on Multi-Task MR and 4D-CT Imaging for Radiation Treatment Planning
    Location: Room 152
    Presenter: Oi Wai Chau, PhD – Mayo Clinic Alix School of Medicine
  • 10:45 AM – 10:55 AM ET
    214 - Transgender and Non-Binary Use of Gender-Affirming Hormone Therapy and Effects on PSA and Prostate Cancer Detection
    Location: Room 140
    Presenter: Paul Riviere, MD – UCSD Radiation Medicine and Applied Sciences
  • 10:55 AM – 11:05 AM ET
    215 - Centering Black Voices: Factors Influencing a Cancer Patients Decision to Join a Clinical Trial
    Location: Room 140
    Presenter: Charlyn Gomez, BS – University of Maryland School of Medicine
  • 11:05 AM – 11:15 AM ET
    216 - Identification of a High-Risk Population in the United States for Anti-EBV Serologic Screening for Nasopharyngeal Carcinoma
    Location: Room 140
    Presenter: Payton Clark, BS – Cleveland Clinic Foundation
  • 11:15 AM – 11:25 AM ET
    217 - Cancer Screening Knowledge and Interest in Incarcerated Women
    Location: Room 140
    Presenter: Bradley Eckelmann, MD, PhD – University of Wisconsin Hospitals and Clinics
  • 11:25 AM – 11:35 AM ET
    218 - Paid Medical Leave and Mortality Risk in Working Cancer Survivors
    Location: Room 140
    Presenter: Abigail Kohut-Jackson, BS, MBS – Saint Louis University School of Medicine
  • 11:35 AM – 11:45 AM ET
    218a - Can Radiotherapy Quality Assurance (RT QA) Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries (LMICs) - Technical Results of the Second Phase of a Prospective International Ato
    Location: Room 140
    Presenter: June Corry, MD – GenesisCare
  • 11:45 AM – 11:55 AM ET
    Discussant
    Location: Room 140
    Discussant: Vonetta Williams, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM – 10:55 AM ET
    181 - Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus
    Location: Room 202
    Presenter: Karen Hoffman, MD, FASTRO – MD Anderson Cancer Center
  • 10:55 AM – 11:05 AM ET
    182 - Quality of Life in Patients Enrolled in a Randomized Clinical Trial Evaluating Hypofractionated Radiotherapy for Intermediate Risk Prostate Cancer
    Location: Room 202
    Presenter: Noelia Sanmamed, MD, PhD – Hospital Clinico San Carlos
  • 11:05 AM – 11:15 AM ET
    183 - Prospective Evaluation of Supplemental External Beam Radiotherapy in Higher - Risk Prostate Cancer Patients Implanted with Pd-103: Long-Term Results of the 44/20/0 Trials
    Location: Room 202
    Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
  • 11:15 AM – 11:25 AM ET
    184 - A Randomized Comparison of Low Dose Rate or High Dose Rate Brachytherapy Combined with External Beam Radiation for Unfavorable Intermediate or High Risk Prostate Cancer: Efficacy Results at Median 6 Y
    Location: Room 202
    Presenter: Juanita Crook, MD – BCCancer
  • 11:25 AM – 11:35 AM ET
    185 - Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial
    Location: Room 202
    Presenter: Comron Hassanzadeh, MD, MPH – MD Anderson Cancer Center
  • 11:35 AM – 11:45 AM ET
    186 - Randomized Controlled Trial of PSMA-PET Image Guided Intensification of Salvage Radiotherapy after Radical Prostatectomy: Which Patients Are Most Likely to Benefit and Other Secondary Analyses
    Location: Room 202
    Presenter: Colin Belliveau, MD – Centre Hospitalier de l'Universite de Montreal (CHUM)
  • 11:45 AM – 11:55 AM ET
    187 - Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial
    Location: Room 202
    Presenter: John Michael Bryant, MD – Moffitt Cancer Center
  • 10:45 AM – 10:55 AM ET
    202 - Bridging Radiotherapy for Patients with Limited (<5 Disease Sites) Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma prior to CAR T-Cell Therapy
    Location: Room 144
    Presenter: Omran Saifi, MD – Mayo Clinic Florida
  • 10:55 AM – 11:05 AM ET
    204 - Improvement in Radiomic Features Following Bridging Therapy is Prognostic for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome
    Location: Room 144
    Presenter: Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center
  • 11:05 AM – 11:15 AM ET
    205 - Multi-Institutional Update on Salvage Radiation Therapy in Relapsed/Refractory Large B Cell Lymphoma Patients in Post-CAR T Cell Therapy Failure
    Location: Room 144
    Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
  • 11:15 AM – 11:25 AM ET
    206 - Does CAR T-Cell Level during Post-CART DLBCL Progression Influence the Response to Salvage Radiotherapy and Patient Outcomes?
    Location: Room 144
    Presenter: Jiaqi Fan, MD – University Cologne
  • 11:25 AM – 11:35 AM ET
    207 - Phase I Hypofractionation Trial of Relapsed/Refractory Lymphoma: Preliminary Results
    Location: Room 144
    Presenter: Greeshma Rajeev-Kumar, MD – University of Chicago Medicine
  • 11:35 AM – 11:45 AM ET
    203 - Defining the Role of Radiotherapy for Indolent, Primary Cutaneous B-Cell Lymphoma - First Results from a Multicenter Registry by the International Lymphoma Radiation Oncology Group (ILROG)
    Location: Room 144
    Presenter: Michael Oertel, MD – University Hospital of Muenster
  • 11:45 AM – 11:55 AM ET
    Discussant
    Location: Room 144
    Discussant: John Plastaras, MD, PhD – University of Pennsylvania
  • 10:45 AM – 10:55 AM ET
    188 - Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
    Location: Room 207
    Presenter: Emily Lebow, MD – University of Pennsylvania
  • 10:55 AM – 11:05 AM ET
    189 - Hypofractionated Radiotherapy plus Concurrent Chemotherapy with or without Consolidation Immunotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer (GASTO-1052)
    Location: Room 207
    Presenter: Hui Liu, MD, PhD – Sun Yat-Sen University Cancer Center
  • 11:05 AM – 11:15 AM ET
    190 - The Selective Personalized RadioImmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes
    Location: Room 207
    Presenter: Nitin Ohri, MD, MS – Montefiore Einstein Comprehensive Cancer Center
  • 11:15 AM – 11:25 AM ET
    191 - Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer: FLARE-RT Mature Outcomes and Patterns of Failure
    Location: Room 207
    Presenter: Sunan Cui, PhD – University of Washington
  • 11:25 AM – 11:35 AM ET
    192 - A Phase 2 Single-Arm Trial of High-Dose Radiotherapy Added to Immunotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
    Location: Room 207
    Presenter: Nikhil Kotha, MD – Stanford Radiation Oncology
  • 11:35 AM – 11:45 AM ET
    193 - Durvalumab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small-Cell Lung Cancer: A Prospective, Single-Arm, Phase II Clinical Trial
    Location: Room 207
    Presenter: Wen Bin Shen, MD – The Fourth Hospital of Hebei Medical University
  • 11:45 AM – 11:55 AM ET
    194 - Simultaneous Integrated Boost vs. Conventional Radiotherapy for Patients with Limited-Stage Small Cell Lung Cancer: A Randomized, Non-Inferiority, Open-Label, Phase 3 Trial
    Location: Room 207
    Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
  • 10:45 AM – 10:55 AM ET
    208 - Assessment of Circulating Tumor Cells in Oligometastatic Castration-Sensitive Prostate Cancer Patients from the ORIOLE Trial
    Location: Room 150
    Presenter: Soha Bazyar, MD, PhD – University of Maryland
  • 10:55 AM – 11:05 AM ET
    209 - Does Detection of Tumor-Associated Mutations in Proximal Lymph Predict Relapse in HPV-Negative Head and Neck Cancer Patients?
    Location: Room 150
    Presenter: Aadel Chaudhuri, MD, PhD – Mayo Clinic Alix School of Medicine
  • 11:05 AM – 11:15 AM ET
    210 - Associations Between Genetic Alterations in Follicular Lymphoma and Radiosensitivity
    Location: Room 150
    Presenter: N. Ari Wijetunga, MD, PhD, MS – University of North Carolina
  • 11:15 AM – 11:25 AM ET
    211 - Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
    Location: Room 150
    Presenter: Alexander Goglia, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 11:25 AM – 11:35 AM ET
    212 - Characterizing Radiation Induced Subclonal Kinetics in Pancreatic Ductal Adenocarcinoma
    Location: Room 150
    Presenter: Vincent Bernard Pagan, MD, PhD – MD Anderson Cancer Center
  • 11:35 AM – 11:45 AM ET
    213 - Circulating Tumor Cell-Based Molecular Biomarkers of 177Lu-PSMA-617 Treatment Efficacy in Metastatic Prostate Cancer
    Location: Room 150
    Presenter: David Miyamoto, MD, PhD – Massachusetts General Hospital
  • 11:45 AM – 11:55 AM ET
    Discussant
    Location: Room 150
    Discussant: Kent Mouw, MD, PhD – Dana-Farber/Brigham and Women's Cancer Center
  • 10:45 AM – 10:55 AM ET
    195 - A Deep Learning-Driven Framework for Large Language Model-Assisted Automatic Target Volume Localization and Delineation for Enhancing Spinal Metastases Stereotactic Body Radiotherapy Workflow
    Location: Room 145
    Presenter: Zi Yang, PhD – Stanford University
  • 10:55 AM – 11:05 AM ET
    196 - Identifying Candidates for Postoperative Radiotherapy in Patients with Non-Small Lung Cancer: Multicenter Deep Learning Model Development and Prospective Validation
    Location: Room 145
    Presenter: Zeliang Ma, MD – Mayo Clinic Rochester
  • 11:05 AM – 11:15 AM ET
    197 - SAM-ART: An Efficient Segmentation Method with a Large Vision Model for MRI-Guided Adaptive Radiotherapy
    Location: Room 145
    Presenter: Bining Yang, PhD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
  • 11:15 AM – 11:25 AM ET
    198 - Deep Learning-Based Quick MLC Sequencing for MRI-Guided Online Adaptive Radiotherapy
    Location: Room 145
    Presenter: Ahmet Ahunbay, BS – Medical College of Wisconsin
  • 11:25 AM – 11:35 AM ET
    199 - A Reinforcement Learning Approach to Automate Breast Radiation Therapy Treatment Planning Using Electronic Compensation (ECOMP)
    Location: Room 145
    Presenter: Dongrong Yang, MS, BS – Duke University Medical Center
  • 11:35 AM – 11:45 AM ET
    200 - Automated Treatment Planning with Deep Reinforcement Learning for Head-and-Neck Cancer Intensity Modulated Radiation Therapy
    Location: Room 145
    Presenter: Dongrong Yang, MS, BS – Duke University Medical Center
  • 11:45 AM – 11:55 AM ET
    201 - Gross Tumor Volume Auto Delineation Based on a Novel Multimodal Adaptive Segmentation Model in Multicenter Nasopharyngeal Carcinoma Radiotherapy
    Location: Room 145
    Presenter: Hongfei Sun, PhD
  • 1:30 PM – 1:40 PM ET
    1 - A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505)
    Location: Ballroom A/B/C
    Presenter: Matthew Poppe, MD, FASTRO – University of Utah Huntsman Cancer Institute
  • 1:40 PM – 1:50 PM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Kathleen Horst, MD – Stanford University
  • 1:50 PM – 2:00 PM ET
    LBA01 - Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer
    Location: Ballroom A/B/C
    Presenter: Jason Efstathiou, MD, PhD, FASTRO – Massachusetts General Hospital
  • 2:00 PM – 2:10 PM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Curtiland Deville, MD, FASTRO – Johns Hopkins University
  • 2:10 PM – 2:20 PM ET
    LBA02 - Concurrent Chemoradiation +/- Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005
    Location: Ballroom A/B/C
    Presenter: Kristin Higgins, MD – City of Hope Atlanta
  • 2:20 PM – 2:30 PM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Robert Samstein, MD, PhD – Icahn School of Medicine at Mount Sinai
  • 2:30 PM – 2:40 PM ET
    LBA03 - Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients
    Location: Ballroom A/B/C
    Presenter: Sue Yom, MD, PhD, FASTRO – UCSF Bakar Precision Medicine Cancer Center
  • 2:40 PM – 2:50 PM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Sewit Teckie, MD, MBA – New York City Health and Hospitals
  • 3:00 PM – 3:10 PM ET
    219 - Renal Function after Definitive Local Therapy for Primary Renal Cell Carcinoma: A Meta-Analysis
    Location: Room 207
    Presenter: Nicholas Zaorsky, MD, MS – University Hospitals Case Medical Center
  • 3:10 PM – 3:20 PM ET
    220 - Pembrolizumab Monotherapy Following Tri-Modality Treatment for Selected Patients with Muscle-Invasive Bladder Cancer
    Location: Room 207
  • 3:20 PM – 3:30 PM ET
    221 - Exploratory Analyses of Stereotactic Ablative Radiotherapy for Bladder Preservation in Elderly Bladder Cancer Patients: Phase I Results
    Location: Room 207
    Presenter: Yun Bai, MD – Peking University First Hospital
  • 3:30 PM – 3:40 PM ET
    222 - Bi-Institutional Safety Analysis of Combining Radiotherapy and Enfortumab Vedotin in Advanced Urothelial Cancer
    Location: Room 207
    Presenter: Yash Soni, MD, BS – UT Southwestern Medical Center
  • 3:40 PM – 3:50 PM ET
    223 - Oncological Outcomes and Toxicities of Brachytherapy for Carcinomas of the Penis: A Bi-Centric Study by the SFRO Brachytherapy Group
    Location: Room 207
    Presenter: Kanta Ka, MD, MS – Gustave Roussy Cancer Center
  • 3:50 PM – 4:00 PM ET
    224 - Natural History after Likely Cure vs. Recurrence vs. after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials
    Location: Room 207
    Presenter: Soumyajit Roy, MS, MBBS – Rush University Medical Center
  • 3:00 PM – 3:10 PM ET
    231 - Failure Modes and Root Cause Analysis for CBCT-Guided Online Adaptive Radiotherapy of the Pelvis
    Location: Room 209
    Presenter: Dandan Zheng, PhD – University of Rochester
  • 3:10 PM – 3:20 PM ET
    232 - Optimized Hybrid Model for Radiation Incident Reporting in Multi-Site Centers
    Location: Room 209
    Presenter: Xing Li, PhD – Inova Schar Cancer Institute
  • 3:20 PM – 3:30 PM ET
    233 - Peer Review Implementation: From Chart Rounds to the Bedside
    Location: Room 209
    Presenter: Chad Caraway, MS – Eastern Virginia Medical School
  • 3:30 PM – 3:40 PM ET
    234 - Analysis of Protocol Deviations at a Large Multi-Center Academic Radiation Oncology Department to Improve Patient Safety
    Location: Room 209
    Presenter: Manav Shah, BS – Northwell Health
  • 3:40 PM – 3:50 PM ET
    235 - Enhancing Patient Safety in Radiotherapy with a Novel AI-Powered Risk Management Tool
    Location: Room 209
    Presenter: Evangelos Pappas, PhD – University of West Attica
  • 3:50 PM – 4:00 PM ET
    236 - "If You're Talking, I Think You're Muted:" Follow-Up Analysis of Weekly Peer Review Discussion and Deviation Detection after Transitioning from Virtual to In-Person Format
    Location: Room 209
    Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
  • 3:00 PM – 3:10 PM ET
    225 - Early Clinical Insights into FDG-Guided Radiotherapy Planning and Delivery on a Novel PET-Linac Platform in Patients with Lung and Bone Lesions: Pioneering Real-Time Biology-Guided Radiotherapy
    Location: Room 145
    Presenter: Bin Cai, PhD – University of Texas Southwestern Medical Center
  • 3:10 PM – 3:20 PM ET
    226 - Toward Adaptive Dose Painting with Hypoxia Biomarkers: Feasibility of Oxygen-Enhanced (OE)-MRI T1 Mapping on Low-Field MR-Linac
    Location: Room 145
    Presenter: Claire Park, PhD, BS – Memorial Sloan Kettering Cancer Center
  • 3:20 PM – 3:30 PM ET
    227 - Pathologic Response Prediction Value of 18f-Fapi PET/CT in ESCC Treated with Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    Location: Room 145
    Presenter: Yuchun Wei, MD, PhD – Shandong Cancer Hospital and Institute
  • 3:30 PM – 3:40 PM ET
    228 - Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers
    Location: Room 145
    Presenter: Rachel Minne, MS, BS – University of Wisconsin School of Medicine and Public Health
  • 3:40 PM – 3:50 PM ET
    229 - APTw Imaging for Personalized Target Delineation of Glioblastoma
    Location: Room 145
    Presenter: Patrick Tang, MSc – Erasmus MC Cancer Institute
  • 3:50 PM – 4:00 PM ET
    230 - Feasibility of Biology-Guided Radiotherapy with Gallium-68 PSMA-11 Radiotracer for Bony Metastases in Prostate Cancer Patients
    Location: Room 145
    Presenter: Chunhui Han, PhD – City of Hope National Medical Center
  • 3:00 PM – 3:05 PM ET
    Introduction
    Location: Room 143
  • 3:05 PM – 3:10 PM ET
    1012 - Changes in Employment and Practice Locations among Radiation Oncologists: 2015 - 2023
    Location: Room 143
    Presenter: Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU
  • 3:10 PM – 3:15 PM ET
    1013 - High Deductible Health Plans and Survival among Cancer Survivors and the Role of Cost-Driven Delayed or Forgone Medical Care
    Location: Room 143
    Presenter: Justin Barnes, MD, MS – Washington University School of Medicine
  • 3:15 PM – 3:20 PM ET
    1014 - Radiotherapy Utilization and Spending in Patients with Traditional Medicare Compared to Medicare Advantage
    Location: Room 143
    Presenter: Jacob Hogan, BS – Washington University in St. Louis School of Medicine
  • 3:20 PM – 3:25 PM ET
    1016 - Hypofractionated Radiotherapy for Prostate Cancer: Preliminary Results from the HypoAfrica Study
    Location: Room 143
    Presenter: Adedayo Joseph, MD – Lagos University Teaching Hospital
  • 3:25 PM – 3:30 PM ET
    1017 - Trends and Variation in Spending for Radiation Treatment Episodes for Medicare Patients with Cancer
    Location: Room 143
    Presenter: Miranda Lam, MD, MBA – Brigham and Women's Hospital/Dana-Farber
  • 3:30 PM – 3:55 PM ET
    Question and Answers
    Location: Room 143
  • 3:55 PM – 4:00 PM ET
    Closing
    Location: Room 143
  • 5:00 PM – 5:10 PM ET
    237 - Five vs. Three Fractions of Prone Accelerated Partial Breast Irradiation: Results of a Randomized Controlled Phase 3 Non-Inferiority Trial
    Location: Room 202
    Presenter: Naamit Gerber, MD – NYU Langone Medical Center
  • 5:10 PM – 5:20 PM ET
    238 - Single-Institution Phase 1/2 Prospective Trial Evaluating Three-Fraction Partial Breast Irradiation: Four Year Outcomes Including Quantitative Cosmesis and Patient-Reported Outcomes
    Location: Room 202
    Presenter: Silpa Raju, MD – Washington University in St. Louis
  • 5:20 PM – 5:30 PM ET
    239 - Clinical Outcomes of Patients with Early-Stage Breast Cancer Treated with Five-Fraction Partial Breast Irradiation vs. Intraoperative Radiation Therapy
    Location: Room 202
    Presenter: Anirudh Bommireddy, MD – Anirudh Bommireddy
  • 5:30 PM – 5:40 PM ET
    240 - Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Sensitive Breast Cancer
    Location: Room 202
    Presenter: David Lakomy, MD – Washington University in St. Louis
  • 5:40 PM – 5:50 PM ET
    241 - Comparison of Acute and Late Toxicities with Daily vs. Every Other Day Five Fraction Partial Breast Radiation Therapy
    Location: Room 202
    Presenter: Sean Parker, MD – Cleveland Clinic Health System
  • 5:50 PM – 6:00 PM ET
    Discussant
    Location: Room 202
    Discussant: Chirag Shah, MD – Cleveland Clinic
  • 5:00 PM – 5:10 PM ET
    252 - Long-Term Update of a Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma
    Location: Room 144
    Presenter: Christina Huang, MD, MS – Duke University School of Medicine
  • 5:10 PM – 5:20 PM ET
    253 - Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
    Location: Room 144
    Presenter: Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center
  • 5:20 PM – 5:30 PM ET
    254 - Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Childrens Oncology Group AHOD 0431
    Location: Room 144
    Presenter: Sarah Milgrom, MD – University of Colorado Denver
  • 5:30 PM – 5:40 PM ET
    255 - Initial Results of the Multicenter Phase II Trial of a Novel Hypofractionated Low-Dose Radiotherapy for Indolent Non-Hodgkin Lymphoma
    Location: Room 144
    Presenter: Xinyue Wang, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 5:40 PM – 5:50 PM ET
    256 - A Proof-of-Principle Study of Split-Course Bridging Radiotherapy (SC-BRT) prior to Commercial CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: Results from Phase 1a Pilot Cohort
    Location: Room 144
    Presenter: Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center
  • 5:50 PM – 6:00 PM ET
    Discussant
    Location: Room 144
    Discussant: Hans Theodor Eich, MD, PhD – University of Muenster
  • 5:00 PM – 5:10 PM ET
    242 - Long-Term Outcomes of Postoperative Radiotherapy for Patients with pIIIA-N2 Non-Small Cell Lung Cancer after Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial
    Location: Room 207
    Presenter: Yu Men, MD – CICAMS and PUMC
  • 5:10 PM – 5:20 PM ET
    243 - Long-Term Outcomes of a Prospective Randomized Trial of Passive Scattering Proton Therapy vs. Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
    Location: Room 207
    Presenter: Tingshi Su, MD, PhD – MD Anderson Cancer Center
  • 5:20 PM – 5:30 PM ET
    244 - The Impact of Prophylactic Bisphosphonates on Radiation-Induced Rib Fractures and Chest Wall Pain in Peripheral Lung Tumor SBRT: A Randomized, Double-Blind, Placebo-Controlled Study
    Location: Room 207
    Presenter: Michael Farris, MD – Wake Forest University Medical Center
  • 5:30 PM – 5:40 PM ET
    245 - Incidence of Pulmonary Hypertension and Association with Pulmonary Artery Radiation Dose in Lung Cancer Radiotherapy
    Location: Room 207
    Presenter: Katelyn Atkins, MD, PhD – Cedars-Sinai Medical Center
  • 5:40 PM – 5:50 PM ET
    246 - Exploratory Analysis of ctDNA and Imaging Response in the Phase I/II CHORUS Study of Canakinumab with Chemoradiation and Durvalumab Consolidation for Stage III NSCLC
    Location: Room 207
    Presenter: Narek Shaverdian, MD – Memorial Sloan Kettering Cancer Center
  • 5:00 PM – 5:10 PM ET
    247 - A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes
    Location: Room 143
    Presenter: John Nikitas, MD – UCLA Radiation Oncology
  • 5:10 PM – 5:20 PM ET
    248 - The Impact of Hypofractionated Pre-Operative Radiation Therapy on PD-L1 Expression in Soft Tissue Sarcomas
    Location: Room 143
    Presenter: Manpreet Bedi, MD, MS – Medical College of Wisconsin Affiliated Hospitals
  • 5:20 PM – 5:30 PM ET
    249 - Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma
    Location: Room 143
    Presenter: Arash Naghavi, MD, MS – H. Lee Moffitt Cancer Center and Research Institute
  • 5:30 PM – 5:40 PM ET
    250 - Reduction of Bone Fracture after Radiotherapy in Lower Extremity Soft Tissue Sarcoma after Implementing Bone Avoidance Objectives for Radiotherapy Planning
    Location: Room 143
    Presenter: David Kirsch, MD, PhD, FASTRO – Princess Margaret Cancer Centre
  • 5:40 PM – 5:50 PM ET
    251 - Immune Profiling of "Radvax" Abscopal Responses in Metastatic Melanoma Patients Progressing on Anti-PD1 Therapy Treated with Hypofractionated Radiotherapy (HFRT) to One Lesion Combined with Pembrolizu
    Location: Room 143
    Presenter: John Lukens, MD – Hospital of the University of Pennsylvania
  • 5:50 PM – 6:00 PM ET
    Discussant
    Location: Room 143
    Discussant: B. Ashleigh Guadagnolo, MD, FASTRO, MPH – MD Anderson Cancer Center
  • 5:00 PM – 5:05 PM ET
    Introduction
    Location: Room 152
  • 5:05 PM – 5:10 PM ET
    1018 - Dose-Escalated Hypofractionated Adaptive Radiotherapy (DEHART) and 60 Gy in 15 Fractions for Advanced Head and Neck Cancers: An Interim Analysis of a Phase I Trial
    Location: Room 152
    Presenter: Musaddiq Awan, MD – Medical College of Wisconsin
  • 5:10 PM – 5:15 PM ET
    1019 - Neoadjuvant Chemoimmunotherapy Followed by Surgery and Response-Adapted Adjuvant Radiotherapy for Head and Neck Squamous Cell Carcinoma
    Location: Room 152
    Presenter: Yuan Wu, MD – Hubei Cancer Hospital
  • 5:15 PM – 5:20 PM ET
    1020 - Oxygen-Enhanced MRI in Patients with p16-Positive Oropharyngeal Cancer Undergoing (Chemo)-Radiotherapy
    Location: Room 152
    Presenter: James Price, MBBS, FRCR – The Christie NHS Foundation Trust
  • 5:20 PM – 5:25 PM ET
    1021 - Prognostic Value of Image-Identified Extranodal Extension and Potential Role in Cn Classification in HPV-Negative Oropharyngeal Cancer: A Multi-Center Cohort Study
    Location: Room 152
    Presenter: Shao Hui Huang, MS, RT – Princess Margaret Cancer Centre
  • 5:25 PM – 5:30 PM ET
    1022 - ACRIN 6685 PET-CT Threshold to Reinterpret Pre-Treatment Head and Neck Cancer (HNC) Imaging? Stage Migration and Treatment Outcomes
    Location: Room 152
    Presenter: Nuverah Mohsin, MD, BS – Fox Chase Cancer Center
  • 5:30 PM – 5:35 PM ET
    1023 - Treatment Response-Adapted Risk Index Model for Survival Prediction and Adjuvant Chemotherapy Selection in Nonmetastatic Nasopharyngeal Carcinoma
    Location: Room 152
    Presenter: Yang Liu, MD – Cancer Hospital Chinese Academy of Medical Sciences
  • 5:35 PM – 5:55 PM ET
    Questions and Answers
    Location: Room 152
  • 5:55 PM – 6:00 PM ET
    Closing
    Location: Room 152
  • 5:00 PM – 5:05 PM ET
    Introduction
    Location: Room 147
  • 5:05 PM – 5:10 PM ET
    1024 - CT-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors
    Location: Room 147
    Presenter: Alexander Lukez, MD – Fox Chase Cancer Center
  • 5:10 PM – 5:15 PM ET
    1025 - Establishment of a Trigger Decision Model for Cervical Cancer in Real-Time Online Adaptive Radiotherapy
    Location: Room 147
    Presenter: Chenying Ma, MD, PhD – The First Affiliated Hospital of Soochow University
  • 5:15 PM – 5:20 PM ET
    1026 - Fast Tracking MR Only Adaptive Radiotherapy; Automatic Segmentation on Planning, Daily MRI and Synthetic CT
    Location: Room 147
    Presenter: Asma Amjad, PhD – Medical College of Wisconsin
  • 5:20 PM – 5:25 PM ET
    1027 - Optimizing Adaptive Radiation Therapy for Cervical Cancer: When is the Best Time to Adapt and Who Benefits the Most
    Location: Room 147
    Presenter: Asya Pitre, BA – Texas College of Osteopathic Medicine
  • 5:25 PM – 5:30 PM ET
    1028 - Comparison of MRI-Linac to Standalone MRI Volumes in Glioblastoma: Implications for Adaptive Radiotherapy and Contrast Imaging
    Location: Room 147
    Presenter: Kaylie Cullison, PhD, BS – University of Miami Sylvester Comprehensive Cancer Center
  • 5:30 PM – 5:35 PM ET
    1029 - Integrating Laser Surface Mapping with CBCT for Enhanced Decision Support from ML Guided Resimulation Predictions
    Location: Room 147
    Presenter: Stephen Shang, PhD – South Florida Proton Therapy Institute
  • 5:35 PM – 5:55 PM ET
    Questions and Answers
    Location: Room 147
  • 5:55 PM – 6:00 PM ET
    Closing
    Location: Room 147